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Abstract 
Homeostatically regulated slow-wave oscillations in nonREM sleep may reflect synaptic 
changes across the sleep-wake continuum, and the restorative function of sleep. The non-synonymous 
c.22G>A polymorphism (rs73598374) of adenosine deaminase (ADA) reduces the conversion of 
adenosine to inosine, and predicts baseline differences in sleep slow-wave oscillations. We 
hypothesized that this polymorphism affects cognitive functions, and investigated whether it 
modulates EEG, behavioral, subjective, and biochemical responses to sleep deprivation. Attention, 
learning, memory, and executive functioning were quantified in healthy adults. Right-handed carriers 
of the variant allele (G/A genotype, n = 29) performed worse on the d2 attention task than G/G 
homozygotes (n = 191). To test whether this difference reflects elevated homeostatic sleep pressure, 
sleep and sleep EEG before and after sleep deprivation were studied in 2 prospectively matched 
groups of G/A and G/G genotype subjects. Deep sleep and EEG 0.75-1.5 Hz oscillations in nonREM 
sleep were significantly higher in G/A than in G/G genotype. Moreover, attention and vigor were 
reduced, whereas waking EEG alpha activity (8.5-12 Hz), sleepiness, fatigue, and α-amylase in saliva 
were enhanced. These convergent data demonstrate that genetic reduction of ADA activity elevates 
sleep pressure and plays a key role in sleep and waking quality in humans. 
 
 
Keywords: adenosine deaminase; cognitive performance; plasticity; slow wave sleep; synaptic 
homeostasis 
 
Page 5 of 42 Cerebral Cortex
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Bachmann et al. ADA genotype and sleep homeostasis 
 3
Introduction 
Sleep homeostasis refers to the general principle that elevated sleep need following sleep loss 
is counteracted by prolonged sleep duration and, especially, by enhanced sleep intensity (Borbély 
1980, 1982; Daan et al. 1984). A highly predictable and reliable marker of non-rapid-eye-movement 
(nonREM) sleep intensity is the prevalence of slow-wave oscillations in the electroencephalogram 
(EEG). Accumulating evidence indicates that EEG slow-wave oscillations in nonREM sleep are 
causally linked to local synaptic processes, which reflect the duration and quality of prior wakefulness 
(Rao et al. 2007; Massimini et al. 2009). Homer 1a, brain-derived neurotrophic factor (BDNF), and 
other molecular markers of brain plasticity were recently suggested to play causal roles in sleep 
homeostasis (Maret et al. 2007; Faraguna et al. 2008). 
Slow (delta) wave oscillations characterizing deep nonREM sleep consist at the cellular level 
of rhythmic alternations in the membrane potential of cortical neurons between a hyperpolarized 
down-state and a depolarized up-state (Steriade et al. 1993). Given their tight homeostatic regulation 
(Bersagliere and Achermann 2010), slow waves are thought to be essential for the functions of sleep, 
which may include synaptic homeostasis, learning, and consolidation of memories (Tononi and Cirelli 
2006; Diekelmann and Born 2010). In support of these views, pharmacological and electrical 
induction of slow-wave oscillations during sleep may potentiate memories and reduce the detrimental 
consequences of sleep restriction on cognitive performance (Marshall et al. 2006; Walsh et al. 2006; 
Walsh et al. 2010). By contrast, sleep deprivation and experimental slow wave suppression may 
impair many cognitive abilities such as attention, perceptual processing and learning, hippocampal 
activation, and memory encoding (Aeschbach et al. 2008; Landsness et al. 2009; Tomasi et al. 2009; 
Van Der Werf et al. 2009). 
The molecular and neurochemical bases of sleep homeostasis, and the relationships between 
waking brain activity and sleep slow-wave oscillations are poorly understood. However, adenosine 
and its receptors play a well-established role in sleep homeostasis (Basheer et al. 2004; Landolt 2008). 
Moreover, in vitro data show that for example the facilitatory action of BDNF on long-term 
potentiation (LTP) requires endogenous adenosine. More specifically, enhanced LTP by BDNF in 
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hippocampal slices was prevented when adenosine was removed with the adenosine metabolizing 
enzyme adenosine deaminase (ADA) (Fontinha et al. 2008). Thus, it is possible that BDNF and the 
adenosine neuromodulator system interact to mediate the consequences of neural activity during 
wakefulness on the homeostatic regulation of nonREM sleep. 
Adenosine kinase (ADK) and ADA contribute to the regulation of extracellular adenosine 
levels (Fredholm et al. 2005). Not only ADK (Palchykova et al. 2010) but also ADA may be involved 
in homeostatic sleep-wake regulation. Converging genetic and pharmacological studies in mice and 
rats indicate an important role for Ada in regulating the build-up of nonREM sleep need during 
prolonged wakefulness, as well as nonREM sleep intensity (Franken et al. 2001; Okada et al. 2003). 
In humans, a functional G>A transition at nucleotide position 22 of the coding sequence of the ADA 
gene (c.22G>A; rs73598374) is associated with enhanced slow-wave activity in baseline sleep (Rétey 
et al. 2005). While these data suggest that this genetic variation increases nonREM sleep pressure, the 
answers to the questions whether it also affects cognitive performance and sleep homeostasis are 
unknown. 
Heterozygous G/A allele carriers of ADA show reduced ADA enzymatic activity (Battistuzzi 
et al. 1981; Riksen et al. 2008) and may have higher endogenous adenosine levels than homozygous 
G/G genotype subjects (Hirschhorn et al. 1994). We investigated the functional consequences of the 
c.22G>A polymorphism in 220 healthy volunteers, and systematically recorded self-reported sleep-
wake habits and quantified cognitive abilities including attention, learning, memory, and executive 
functioning. In a subsequent case-control study in 22 healthy adults, 4-week-rest-activity patterns and 
homeostatic sleep-wake regulation were studied by quantifying neurophysiological, behavioral, 
subjective, and biochemical responses to a night without sleep. Based on the previous findings, we 
hypothesized that the G/A genotype subjects would exhibit higher sleep pressure and habitually sleep 
longer, show more slow wave sleep and slow-wave activity, and be more strongly affected by sleep 
deprivation than the G/G homozygotes. 
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Materials and Methods 
Subject recruitment and genotyping 
The Cantonal ethics committee for research on human subjects reviewed and approved the 
study protocol and all experimental procedures. They were conducted according to the principles of 
the Declaration of Helsinki. All participants provided written informed consent.  
One-hundred-twenty-seven men and 118 women were genotyped. The prevalence of the G/A 
genotype was roughly 13 % (31/245), whereas 87 % had the G/G genotype (214/245) and no 
individual with A/A genotype was present. These genotype frequencies are in accordance with 
previous findings in a healthy Italian population (Persico et al. 2000). Self-reported sleep-wake habits, 
attention, learning, memory, and executive performance were systematically quantified. Because we 
were also interested in lateralized cognitive functions (see supporting information, Table S1) and 
right-handedness guarantees a uniform degree of functional lateralization, only the data of right-
handed individuals (n=220) were analyzed. Among the G/A genotype subjects, 5 healthy women and 
6 healthy men (all Swiss or German) willing to participate in a sleep deprivation study were recruited 
for the laboratory experiment. They were prospectively matched with 11 G/G homozygotes with 
regard to sex, age, years of education, habitual alcohol and caffeine intake, body-mass index, trait 
anxiety, diurnal preference and daytime sleepiness (see supporting information, Table S2). Women 
were matched with respect to the phase in the menstrual cycle (follicular phase, luteal phase). All 
participants reported to have no history of neurological and psychiatric disease, not taking any 
medication, and to be moderate alcohol and caffeine consumers. Two pairs of subjects were matched 
with respect to cigarette smoking (~ 10 cigarettes per day); all other participants were non-smokers. 
Genomic DNA was extracted from 3 ml fresh EDTA blood with the Wizard® Genomic DNA 
purifcation kit (Promega, Madison, WI, USA). Genotypes were determined by allele-specific 
polymerase chain reaction on a MJ Research PTC-225 thermal cycler (MJ Research / Bio-Rad, Reno, 
NV, USA). HOT FIREPol® DNA polymerase and the following primers were used: forward primer, 
5’-gcgcacgagggcaccat-3’; reverse primer, 5’-gaactcgcctgsaggagcc-3’ (annealing temperature, 67° C). 
Sequencing was performed by the Sanger chain-termination method (Sanger et al. 1977) with an ABI 
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PRISM® 3100 (16 capillaries) (Applied Biosystems Inc., Foster City, CA, USA) genetic analyzer. All 
genetic analyses were replicated at least once for independent confirmation of the results. 
 
Habitual sleep duration 
Self-reported habitual sleep length on work and leisure days was quantified with the Munich 
Chronotype Questionnaire (Roenneberg et al. 2003). All participants of the sleep deprivation study 
wore during 4 weeks a rest-activity monitor (Actiwatch, Cambridge Neurotechnology Ltd, 
Cambridge, United Kingdom) on the wrist of their non-dominant arm. Habitual sleep length was 
estimated form the records of the rest-activity patterns, together with inspection of sleep-wake diaries. 
Note that actigraphy-derived “sleep duration” refers to total time in bed, including possible brief 
intrusions of wakefulness. 
 
Attention, learning, memory, and executive functioning 
The cognitive abilities of all study participants were systematically tested during 2 hours. 
The d2 attention task (Brickenkamp 1962) is a timed test of selective attention. Fourteen lines 
of the letters "d" and "p" with 1-4 dashes arranged either individually or in pairs above and below the 
letters are presented on a sheet of paper. The subjects are allowed 20 s to scan each line, and to mark 
all letters "d" with 2 dashes. Outcome measures include the total number of processed items, a highly 
reliable measure of processing speed, the sums of errors of omission and commission, as well as the 
fluctuation rate across trials (Brickenkamp 1962). 
The validated tests used to assess verbal and non-verbal learning efficiency, working memory 
and executive functions included the Rey Auditory Verbal Learning Test (Strauss et al. 2006) the Rey 
Verbal Design Learning Test (Foster et al. 2009), the Digit Span Test (Strauss et al. 2006), a Stroop 
Color-Word Task (Stroop 1935; Perret 1974), the Random Number Generation task (Towse 1998), a 
Go/No-Go Test (Greenwald et al. 1998), a Design Fluency Test (Regard et al. 1982), and a Letter 
Fluency Test (Perret 1974). 
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Laboratory study to examine homeostatic sleep-wake regulation 
All participants of the laboratory study were polysomnographically screened in the sleep lab, 
to exclude poor sleep efficiency and unrecognized, pre-existing sleep disorders. 
The experimental protocol consisted of 4 nights and 2 days in the sleep laboratory. The first 
and second nights (24:00-08:00) served as adaptation and baseline, respectively. The subsequent 2 
days and 1 night, subjects were not allowed to sleep. During the 40 hours prolonged wakefulness, 
they were constantly supervised by members of the research team. Subjects were free to read, study, 
play games, watch movies and occasionally take a walk outside the laboratory. They received normal 
meals 3 times a day, prepared either in the University cafeteria or by themselves in a kitchen adjacent 
to the laboratory. The last night (24:00-10:00) served as recovery night from sleep deprivation. 
 
Pre-study procedures 
For two weeks prior to the study, volunteers were asked to abstain from all sources of 
caffeine (coffee, tea, cola drinks, chocolate, and energy drinks), to wear a wrist activity monitor on 
the non-dominant arm, and to keep a sleep-wake diary. For 3 days before and during the study, all 
subjects had to also abstain from alcohol, and to maintain regular 8:16-hours sleep-wake cycles. Bed 
times were scheduled from 24:00-08:00. When not adhering to the directives, subjects were excluded 
from the study. The smokers were asked to write down the number of cigarettes per day (not more 
than ~ 10 cigarettes per day were allowed). During the study, the two pairs of smokers were allowed 
to smoke at the same pre-defined times, in order to avoid withdrawal. 
 
All-night polysomnography 
Polysomnographic recordings including EEG, bipolar electrooculogram (EOG), mental 
electromyogram (EMG) and electrocardiogram (ECG) were continuously conducted during all 
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 8
experimental nights, with Rembrandt Datalab® (Version 8; Embla Systems, Broomfield, CO, USA) 
and the polygraphic amplifier Artisan® (Micromed, Mogliano Veneto, Italy). Analog signals were 
conditioned by a high-pass filter (EEG: -3 dB at 0.15 Hz; EMG: 10 Hz; ECG: 1 Hz) and an anti-
aliasing low-pass filter (-3 dB at 67.2 Hz), digitized and transmitted via fiber-optic cables to a 
personal computer. Data were sampled with a frequency of 256 Hz. The EEG was recorded from 1 
referential (C3A2) and 8 bipolar derivations along the left and right anteror-posterior axes. The data 
derived from the C3A2 derivation are reported here. 
Sleep stages (Rechtschaffen and Kales 1968) were visually scored for 20-s epochs with 
Rembrandt Analysis Manager® (Version 8; Embla Systems, Broomfield, CO, USA). Four-s EEG 
spectra (FFT routine, Hanning window, 0.25-Hz resolution) were calculated with MATLAB® (The 
MathWorks Inc, Natick, MA, USA), averaged over consecutive 5 epochs, and matched with the sleep 
scores. Twenty-second epochs with movement- and arousal related artifacts were visually identified 
and eliminated. To compute all-night power spectra (0.25-Hz resolution, C3A2 derivation) in 
nonREM (stages 2, 3 & 4) and REM sleep, all artifact-free 20-s values were averaged. In the recovery 
nights, data analysis was restricted to the first 8 hours of the 10-hour sleep opportunities. 
 
Waking EEG recordings 
During the 40 hours prolonged wakefulness, EEG, EMG, EOC and ECG signals were 
recorded in 14 sessions at 3-hour intervals in the same way as during the nights, with Rembrandt 
Datalab® and polygraphic amplifier Artisan®. The first recording was scheduled 15 minutes after 
lights-on from the baseline night. The study participants were instructed to comfortably relax in a 
chair, and to place their chin on an individually-adjusted head-rest. A 3-min recording period with 
eyes closed was followed by a 5-min period with eyes open, while subjects fixated a black dot 
attached to the wall. At least 1 hour before each waking EEG recording, subjects had to stay in the 
laboratory (constant temperature: 19-21 °C, light intensity: < 150 lux), and 15 minutes before each 
recording, they were left by themselves in their bedroom. 
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The bioelectric signals were conditioned in the same way as in the polysomnographic 
recordings. Artifacts in all derivations were visually identified and excluded. The power spectra (Fast 
Fourier Transform, Hanning window) of artifact-free, 50 %-overlapping, 2-s epochs were computed 
with MATLAB® (The MathWorks Inc, Natick, MA, USA). Mean power spectra between 0-20 Hz 
(0.5-Hz resolution, C3A2 derivation) of the 5-min periods with eyes open are reported. 
 
Subjective sleepiness and Profile of Mood States 
To quantify the evolution of subjective sleepiness, a validated German version of the Stanford 
Sleepiness Scale (Sturm and Clarenbach 1997) was administered at 3-hour intervals throughout 
extended wakefulness (first assessment at 08:10 after the baseline night). Subjective sleepiness, vigor, 
depression and anger were also quantified at 16:45 on days 1 and 2 of prolonged wakefulness with the 
Profile of Mood States (McNair et al. 1971). 
 
Psychomotor vigilance task (PVT) 
All participants completed at 3-hour intervals during extended wakefulness fourteen 10-min 
sessions of the psychomotor vigilance task (PVT) (Durmer and Dinges 2005). The task was 
implemented on a PC, using the software e-Prime (Psychology Software Tools Inc., Pittsburgh, PA, 
USA). When a digital millisecond counter started to scroll in the center of the computer screen, 
subjects had to press a button with their right forefinger on a response box connected to the PC. In 
each session, 100 stimuli were presented (random inter-stimulus intervals: 2-10 sec). Subjects 
received oral instructions and performed one training session on the evening prior to the adaptation 
night. 
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 10
Alpha-amylase activity in saliva 
Saliva samples (Salivettes®, Sarstedt, Nümbrecht, Germany) were collected at 2-hour 
intervals throughout prolonged wakefulness, starting at 08:00 after the baseline night. Salivary 
α-amylase activity (sAA), an indirect marker of sympatho-adrenal activity (van Stegeren et al. 2006) 
and a recently proposed biomarker of sleep drive (Seugnet et al. 2006), was determined according to 
previously reported procedures (Nater et al. 2007). 
 
Data analyses and statistics 
Cognitive performance, habitual sleep duration, sleep architecture, sleep and waking EEG, 
subjective sleepiness, mood states, sustained vigilant attention and sAA in baseline and during/after 
sleep deprivation were analyzed in G/A and G/G genotype subjects. All statistical analyses were 
performed with SAS® 9.1.3 software (SAS Institute, Cary, NC). Variables that were not normally 
distributed (absolute EEG power values and response lapses on the PVT) were transformed to 
approximate a normal distribution. Two- and 3-way, mixed-model analyses of variance (ANOVA) 
with the between-subjects factor ‘gender’ (female, male) and the within-subjects factors ‘genotype’ 
(G/A, G/G), ‘condition’ (baseline, recovery/deprivation), ‘nonREM sleep episode’ (1-4), ‘session’ (14 
assessments during prolonged waking) or ‘time’ (7 time points of sAA determination) were 
performed. The significance level was set at α < 0.05. If not stated otherwise, only significant effects 
of factors and interactions are mentioned. Paired and unpaired, 2-tailed t-tests to localize differences 
within and between groups were only performed when the respective main effects and/or interactions 
of the ANOVA were significant. 
 
Results 
The c.22G>A polymorphism of ADA modulates focused attention 
Analysis of the d2 attention task in 29 G/A and 191 G/G genotype subjects with right-hand 
dominance revealed that the G/A genotype processed roughly 30 items less than the G/G genotype 
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 11
(503 ± 12.6 vs. 534 ± 5.3, p < 0.04). This genotype-dependent difference reflects reduced speed in the 
G/A genotype, and was also present in the participants of the laboratory experiment (see below). By 
contrast, the number of commission and omission errors did not differ between the groups. Moreover, 
performance on various tasks reflecting learning, memory, and executive functioning was similar in 
G/A and G/G genotypes of ADA (see supporting information, Table S1) 
 
The c.22G>A polymorphism of ADA does not affect habitual sleep duration 
The Munich Chronotype Questionnaire suggested similar sleep length on work days and 
leisure days in G/A (n = 29) and G/G (n = 191) genotypes (pall > 0.4, data not shown). Four-week rest-
activity monitoring in the participants of the laboratory study confirmed this notion. Irrespectively of 
genotype, habitual sleep duration equaled roughly 7.6-7.7 hours when averaged over work and leisure 
days (see supporting information, Table S3). 
 
The c.22G>A polymorphism of ADA predicts individual differences in slow wave sleep 
Both genotype groups showed normal sleep architecture, including short sleep latency and 
high sleep efficiency in the baseline night (see supporting information, Table S4). Nevertheless, 
corroborating our previous finding (Rétey et al. 2005), the G/A genotype subjects spent more time in 
slow wave sleep than the G/G genotype subjects (123.9 ± 7.2 vs. 100.3 ± 6.1 min, p < 0.001).  
Sleep episode duration, total sleep time, sleep efficiency and slow wave sleep increased in the 
recovery night after sleep loss when compared to the baseline night. On the contrary, sleep latency, 
wakefulness after sleep onset, stage 1, stage 2, and REM sleep were reduced. These sleep loss-
induced changes in sleep architecture were independent of genotype (see supporting information, 
Table S4). 
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 12
The c.G>A polymorphism of ADA predicts higher EEG slow-wave activity in nonREM sleep 
To draw conclusions about possible differences in sleep homeostasis between the genotypes, 
quantitative EEG analyses in sleep and wakefulness are mandatory. Slow-wave (0.75-1.5 Hz) 
oscillatory activity in nonREM sleep was higher in G/A genotype than in G/G genotype, both in 
baseline and recovery nights (Fig. 1A). As a physiological marker of sleep homeostasis, slow-wave 
activity was highest in the first nonREM sleep episode and declined in the course of the night when 
sleep pressure dissipated (Fig. 2). This time course and the rebound after sleep loss were similar in 
both genotypes. The data suggest that the c.22G>A polymorphism of ADA does not interfere with the 
dynamics of sleep homeostasis. Nevertheless, the G/A genotype appears to exhibit higher overt sleep 
pressure than the G/G genotype. Supporting this hypothesis, the relative rebound in the first nonREM 
sleep episode was significantly smaller in A allele carriers than in G/G homozygotes (33.3 ± 7.7 vs. 
52.8 ± 6.9 %, p < 0.05). 
 
The c.22G>A polymorphism of ADA predicts higher EEG theta/alpha activity in nonREM sleep, REM 
sleep and wakefulness 
The genotype-dependent differences in nonREM sleep were not restricted to the slow wave 
range, but also included theta and alpha oscillations. Irrespective of normal (baseline night) or 
elevated (recovery night) sleep pressure, the G/A genotype subjects exhibited higher activity in the 
entire 6.25-10 Hz band when compared to the G/G genotype subjects (Fig. 1A). Suggesting that this 
difference reflects altered EEG generating mechanisms rather than a genotype-specific difference in 
sleep-wake regulation, similar changes were also present in REM sleep (Fig. 1B, 7-12.5 Hz), as well 
as in wakefulness (Fig. 1C, 8.5-12 Hz). To examine whether the c.22G>A polymorphism of ADA 
affects homeostatic and circadian influences on EEG alpha oscillations in waking (Cajochen et al. 
2002), the time course of activity in the 8.5-12 Hz range during extended wakefulness was quantified 
in G/A and G/G genotypes. Consistent with the conclusion that this genetic variation does not affect 
the dynamics of sleep-wake regulation, the genotype-dependent difference in alpha activity persisted 
throughout sleep deprivation and was not modulated by increasing time awake (Fig. 3A). 
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The c.22G>A polymorphism of ADA predicts higher sleepiness during sleep deprivation 
Previous work suggested that increased alpha activity in waking EEG with eyes open may be 
associated with higher subjective sleepiness, and reduced alertness and sustained attention (Oken et 
al. 2006). Investigating the evolution of subjective sleepiness during sleep deprivation showed that 
sleepiness increased in both groups with prolonged time awake and was also modulated by circadian 
influences. The G/A genotypes, however, were sleepier than the G/G genotypes, particularly after the 
night without sleep (Fig. 3B). This conclusion was corroborated by the Profile of Mood States 
(POMS). While sleep loss reduced subjective state in both groups, fatigue was higher and vigor was 
lower in the G/A genotype than the G/G genotype (Fig. 4). By contrast, the other POMS subscales 
were not affected by either sleep deprivation or genotype (data not shown). 
 
The c.22G>A polymorphism of ADA predicts reduced sustained attention during sleep deprivation 
Performance on the psychomotor vigilance task (PVT) is a sensitive measure of sustained 
vigilant attention. Reaction times (RT) and number of response lapses (RT > 500 ms) on the PVT 
were impaired by sleep loss in both ADA genotypes. However, consistent with increased EEG alpha 
activity and elevated subjective sleepiness, G/A genotype subjects performed consistently slower and 
produced more lapses than G/G genotype subjects throughout prolonged wakefulness (Figs. 3C & 
3D). Importantly, the magnitude of the difference between the genotypes was large, comparable to the 
effects of one night without sleep. The data confirm that tonic alertness is impaired in healthy 
individuals with genetically reduced adenosine metabolism. 
To further support this conclusion, performance on the d2 attention task was separately 
examined in the participants of the laboratory experiment. Corroborating the finding in the entire 
study sample, the G/A genotype processed significantly fewer items than the G/G genotype (Fig. 5). 
This difference reflects reduced speed on the d2 task. 
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The c.22G>A polymorphism of ADA predicts elevated α-amylase activity in saliva 
To investigate whether the c.22G>A polymorphism of ADA also affects a recently proposed 
biomarker of sleep drive (Seugnet et al. 2006), we quantified salivary α-amylase activity (sAA) 
throughout prolonged wakefulness. We found a pronounced diurnal variation, with highest values in 
the afternoon and lowest values early at night. Interestingly, sAA in the G/A genotype was 
significantly higher than in the G/G genotype (Fig. 6). These biochemical data are consistent with our 
neurophysiological, subjective and behavioral findings, and support the conclusion that the functional 
G/A polymorphism of ADA is associated with elevated sleep pressure. 
 
Discussion 
This study demonstrates that healthy adults with genetically-reduced ADA activity (G/A 
genotype) exhibit higher nonREM sleep pressure than individuals with unimpaired ADA activity 
(G/G genotype). The carriers of the variant allele have more slow wave sleep, show enhanced brain 
oscillatory activity within 0.75-1.5 and 6-10 Hz in nonREM sleep (the latter effect is independent of 
vigilance/sleep state), feel more sleepy and fatigued, are less vigilant (d2 and PVT attention tasks), 
and present with enhanced α-amylase activity in saliva when compared to G/G homozygotes. These 
convergent findings demonstrate that in rested and sleep-deprived state, the functional c.22G>A 
polymorphism of ADA not only modulates sleep structure and intensity, but also importantly 
contributes to inter-individual differences in waking quality, including sleepiness and attention. By 
contrast, habitual sleep length and the dynamics of the homeostatic response to sleep deprivation are 
unaffected. Taken together, these data suggest that distinct mechanisms underlie the homeostatic 
regulation of sleep intensity and sleep duration. 
It is widely accepted that EEG slow-wave oscillations are the hallmark of deep nonREM 
sleep (slow wave sleep) and constitute the primary marker of sleep homeostasis. At the cellular level, 
slow-wave oscillations consist of depolarized up-states and hyperpolarized down-states in the 
membrane potential of cortical neurons (Steriade et al. 1993). The up-states last for 0.4-0.8 s and the 
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down-states last for 0.3-0.7 s (Amzica and Steriade 1998). These membrane fluctuations result in 
EEG slow oscillations with frequencies of 0.65-1.3 Hz (Bersagliere and Achermann 2010), which 
perfectly coincide with the frequency range that discriminates the EEG in nonREM sleep between 
G/A and G/G genotypes of ADA. Intra-cellular recordings in non-anaesthetized cats suggest that the 
long-lasting hyperpolarized down-states represent periods of disfacilitation, a form of inhibition due 
to reduced activating input from ascending cholinergic and monoaminergic pathways (Steriade et al. 
2001; Timofeev et al. 2001). Extracellular adenosine could contribute to cortical disfacilitation by 
inhibiting basal forebrain and mesopontine cholinergic neurons (Rainnie et al., 1994). Thus, the 
functional c.22G>A polymorphism of ADA may enhance endogenous adenosine levels and amplify 
cortical disfacilitation in deep nonREM sleep. 
Genetic studies in mice and pharmacological experiments in rats and humans also support a 
role for adenosine in modulating low-frequency slow-wave oscillations in nonREM sleep. Recent 
insights suggest that integrated brain circuits consisting of neurons and astrocytes regulate 
extracellular adenosine and adenosine-mediated modulation of neural transmission (Haydon and 
Carmignoto 2006; Halassa and Haydon 2010). Astrocytes can be activated by neurotransmitters from 
adjacent synapses and release chemicals by a process called gliotransmission. The primary molecules 
released by gliotransmission are glutamate, ATP and D-serine (Oliet and Mothet 2006). The ATP is 
rapidly hydrolyzed to adenosine and modulates synaptic activity by acting on adenosine receptors. 
Astrocytic modulation of cortical synapses is relevant for sleep-related EEG rhythms in vivo (Halassa 
and Haydon 2010) More specifically, absence of gliotransmission by dominant-negative inhibition of 
SNARE-dependent membrane fusion (dnSNARE) exclusively in astrocytes decreases the slow 
oscillation in somatosensory cortex (Fellin et al. 2009). Intriguingly, the dnSNARE mice show 
reduced slow-wave activity in nonREM sleep in baseline, as well as in recovery sleep after sleep 
deprivation (Halassa et al. 2009). Reminiscent of the genotype-dependent difference between G/A and 
G/G allele carriers of ADA, the difference to wild-type mice is most pronounced in the 0.5-1.5 Hz 
band in nonREM sleep. 
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Last but not least, the adenosine A1 and A2A receptor antagonist, caffeine, is well-known to 
reduce primarily EEG low-delta frequencies in nonREM sleep in rested and sleep deprived states 
(rats: 0.75-1.5 Hz; humans: 0.75-2.0 Hz) (Schwierin et al. 1996; Landolt et al. 1995; Landolt et al. 
2004). Genetic studies suggest that A2A receptors play a primary role for the effects of caffeine on 
sleep. Mice with A2A receptor loss-of-function have reduced sleep and blunted response to sleep 
deprivation, as well as to the wake-promoting effects of caffeine (Urade et al. 2003; Huang et al. 
2005). Consistent with this notion, the human c.1976T>C polymorphism (rs5751876) of the A2A 
receptor gene (ADORA2A) modulates individual sensitivity to caffeine on sleep (Rétey et al. 2007). 
This polymorphism has also a striking effect on EEG theta/low-alpha (~ 6.5-9.5 Hz) oscillations in 
nonREM sleep, REM sleep and wakefulness (Rétey et al. 2005). The partial overlap of this frequency 
range with the findings in the present study suggests that the repercussions of genetically-altered 
ADA activity may, at least in part, be mediated by adenosine A2A receptors. 
The consequences of genetic abolition of gliotransmission on EEG activity in REM sleep and 
wakefulness in mice are unknown. Remarkably, however, performance on a novel object recognition 
task appears virtually unaffected after prolonged waking in dnSNARE mice when compared to wild-
type animals (Halassa et al. 2009). This phenotype may be reminiscent of the difference in 
performance on d2 and PVT attention tasks between human G/A allele carriers and G/G homozygotes 
of ADA. Although the comparison between exploration of novel objects in rodents and attention 
performance in humans needs to be made with caution, our findings could indicate that the c.22G>A 
polymorphism increases overt homeostatic sleep pressure by interfering with the astrocyte-dependent 
regulation of extracellular adenosine. Indeed, ADA may be more abundantly expressed in astrocytes 
than in neurons (Fredholm et al. 2005). 
Slow-wave oscillations in nonREM sleep are highest in the beginning of the night and most 
pronounced in those brain areas that were disproportionally active during preceding wakefulness 
(Kattler et al. 1994; Ferrara et al. 2002; Huber et al. 2004). Moreover, experimental induction of slow 
waves may potentiate the beneficial effects of sleep (Marshall et al. 2006; Walsh et al. 2006; Walsh et 
al. 2010), whereas their suppression may impair proper functions of brain and body (Aeschbach et al. 
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2008; Tasali et al. 2008; Landsness et al. 2009; Van Der Werf et al. 2009). Thus, slow-wave 
oscillations in nonREM sleep are thought to reflect a restorative function of sleep. Based upon this 
reasoning, the physiologic enhancement of sleep pressure and slow-wave oscillations may be a 
promising strategy to potentiate the positive effects of sleep. Because adenosine and adenosine 
receptors play a well-established role in sleep homeostasis, this neuromodulatory system could 
provide a rational target to intensify sleep, for example in patients with insomnia, shallow sleep and 
disturbed vigilance. Apart from possible unrelated unwanted reactions (Landolt 2008), the present 
genetic study shows that such an approach would likely impair the quality of wakefulness. More 
specifically, waking functions (e.g., sustained attention) could be reduced to an extent that is similar 
to the effect of one night without sleep. Indeed, with respect to another gene variant possibly involved 
in sleep-wake regulation, PER35/5 genotype subjects of the circadian clock gene PERIOD-3 not only 
exhibit more slow wave sleep and EEG low-frequency activity, but are also more impaired by sleep 
deprivation than PER34/4 homozygotes (Viola et al. 2007). Our findings demonstrate that a similar 
sleep phenotype can impair waking performance even in well-rested individuals. 
In conclusion, functional polymorphic variation of ADA in healthy adults distinctly affects 
nonREM sleep intensity, EEG theta/alpha frequencies in sleep and wakefulness, attention, subjective 
sleepiness, and α-amylase activity in saliva. These differences do not mirror differences in habitual 
sleep duration and are robust against the effects of sleep deprivation. Thus, they do not reflect a 
genotype-dependent alteration in the dynamics of sleep homeostasis. This observation is consistent 
with recent findings in monozygotic and dizygotic twins, showing that the pronounced genetic 
influences on the sleep EEG are independent of elevated sleep pressure after sleep loss (De Gennaro 
et al. 2008). Moreover, as shown in rats (Mackiewicz et al. 2003), Ada enzymatic activity is not 
affected by sleep deprivation. The data rather suggest an elevated level in overt, homeostatically-
regulated nonREM sleep propensity in the G/A genotype compared to G/G homozygotes, which may 
be due to elevated adenosinergic tone at the synapse because of genetically-reduced ADA activity. 
Whether this difference directly underlies the observed phenotypes in sleep and wakefulness, or 
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whether it modulates other molecular systems contributing to the homeostatic regulation of sleep 
propensity, remains to be elucidated. 
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Caption to figures 
Figure 1. The functional c.22G>A polymorphism of ADA modulates EEG activity in nonREM sleep, 
REM sleep and wakefulness. EEG power density (C3A2 derivation) between 0-20 Hz in the G/A 
genotype (n = 11) was expressed as a percentage of the corresponding values in the G/G genotype 
(n = 11; horizontal dashed line at 100%). Data in nonREM (A) (stages 2, 3, 4) and REM sleep (B) 
represent all-night values in baseline (white symbols) and recovery nights (black symbols). In the 
waking EEG (C), averaged power over five 5-min recordings at 8 am, 11 am, 2 pm, 5 pm and 8 pm 
on day 1 (baseline, white squares) and day 2 (deprivation, black squares) during prolonged 
wakefulness are represented. Geometric means are plotted for each 0.25 Hz bin in nonREM and REM 
sleep, and for each 0.5 Hz bin in wakefulness. Black triangles denote a significant effect of ‘genotype’ 
(F1,30 ≥ 4.2, p < 0.05) of a 2-way, mixed-model ANOVA with the within-subject factors ‘genotype’ 
(G/A, G/G) and ‘condition’ (baseline, recovery/deprivation). 
Figure 2. The functional c.22G>A polymorphism of ADA predicts higher low-delta activity (C3A2 
derivation, power within 0.75-1.5 Hz) in nonREM sleep (stages 2-4). By contrast, it does not affect 
the time course and the sleep loss-induced rebound of EEG slow wave oscillations after sleep 
deprivation. Mean delta activity in G/A (left panel) and G/G genotypes (right panel) in nonREM sleep 
episodes 1-4 in baseline (grey bars) and recovery nights (black bars) is plotted. Error bars represent 
1 SEM (n = 11). Three-way, mixed-model ANOVA with the within-subject factors ‘genotype’ (G/A, 
G/G), ‘condition’ (baseline, recovery) and ‘nonREM sleep episode’ (1-4) confirmed the significant 
effect of ‘genotype’ (‘genotype’: F1,44.2 = 8.8, p < 0.005). 
** p < 0.01 (recovery vs. baseline; paired, 2-tailed t-test) 
*** p < 0.001 (recovery vs. baseline; paired, 2-tailed t-test) 
Figure 3. The functional c.22G>A polymorphism of ADA predicts higher EEG alpha activity, 
elevated subjective sleepiness and impaired sustained attention during prolonged wakefulness. 
Starting 15 minutes after wakening from the baseline night, 14 test sessions at 3-hour intervals 
consisting of 5-min waking EEG recording, subjective sleepiness rating and testing of sustained 
attention were completed in each individual. Ticks on the x-axis are rounded to the nearest hour. 
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Black circles: G/A genotype (n = 11). Grey circles: G/G genotype (n = 11). Data were analyzed with 
2-way, mixed-model ANOVA with the within-subject factors ‘genotype’ (G/A, G/G) and ‘session’ 
(14 assessments during prolonged waking). (A) Throughout prolonged wakefulness, EEG activity in 
the 8.5-12 Hz range was consistently higher in G/A genotype than in G/G allele carriers (‘genotype’: 
F1,30=10.9, p < 0.003; ‘session’: F13,239=2.3, p < 0.007; ‘genotype’ x ‘session’ interaction: F13,159=0.2, 
p > 0.9). (B) The evolution of subjective sleepiness during sleep deprivation was quantified with the 
Stanford Sleepiness Scale. ANOVA revealed significantly higher sleepiness in the G/A genotype than 
in the G/G genotype (‘genotype’: F1,78= 6.3, p < 0.02; ‘session’: F13,155= 42.1, p < 0.001; ‘genotype’ x 
‘session’ interaction: F13,162= 1.7, p < 0.08). The difference becomes evident after the night without 
sleep. (C) & (D) Sustained attention during prolonged wakefulness was quantified with the PVT. The 
time courses of speed (1/median reaction time [RT]) and response lapses (RT > 500 ms, transformed 
by √x + √(1+x)) are illustrated. All RT < 100 ms (“errors of commission”) were excluded from 
analyses. The G/A genotype performed significantly worse that the G/G genotype throughout 
prolonged waking (speed: ‘genotype’: F1,25= 15.4, p < 0.001; ‘session’: F13,239= 38.6, p < 0.001; 
‘genotype’ x ‘session’ interaction: F13,146= 0.3, p > 0.9; lapses: ‘genotype’: F1,66= 24.5, p < 0.001; 
‘session’: F13,194= 19.5, p < 0.001; ‘genotype’ x ‘session’ interaction: F13,144= 1.1, p > 0.3). 
Figure 4. Elevated fatigue and reduced vigor in G/A genotype (n = 11) compared to G/G genotype 
(n = 11) of ADA. The Profile of Mood States (POMS) was administered at 16:45 on days 1 (baseline, 
grey bars) and 2 (deprivation, black bars) of extended wakefulness. Data represent means + SEM. 
They were analyzed with 2-way, mixed-model ANOVA with the within-subject factors ‘genotype’ 
(G/A, G/G) and ‘condition’ (baseline, deprivation). In rested and sleep-deprived state, fatigue was 
higher and vigor was lower in the G/A genotype (fatigue: ‘genotype’: F1,30= 4.2, p < 0.05 [*]; 
‘condition’: F1,30= 28.8, p < 0.001; ‘genotype’ x ‘condition’ interaction: F1,30= 0.0, p > 0.8; vigor: 
‘genotype’: F1,30= 9.2, p < 0.005 [**]; ‘condition’: F1,30= 16.1, p < 0.001; ‘genotype’ x ‘session’ 
interaction: F1,30= 0.0, p > 0.8). 
Figure 5. Reduced speed on d2 attention task in the G/A genotype compared to the G/G genotype of 
ADA. The upper and lower lines of the “box and whisker plots” represent the 75th and 25th percentiles 
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of the study sample, whereas the horizontal lines in the middle of the boxes indicate the sample 
medians (50th percentiles). Mean values of processed items (dashed lines) differed significantly 
between 11 G/A (white box) and 9 G/G (grey box) genotype subjects (484 ± 19.1 vs. 561 ± 22.6, 
p < 0.02; paired, 2-tailed t-test). By contrast, the number of errors did not differ between the groups. 
Figure 6. Elevated salivary α-amylase activity (sAA) in G/A genotype compared to G/G genotype of 
ADA. Saliva samples were collected at 2-hour intervals, starting at 8 am on day 1 of prolonged 
wakefulness. The sAA (U/ml) was averaged per 6-hour intervals. Error bars represent SEM (n = 11). 
The data were analyzed with 2-way, mixed-model ANOVA with the within-subject factors ‘genotype’ 
(G/A, G/G) and ‘time’ (7 time points during prolonged waking). ANOVA revealed higher sAA in the 
G/A genotype (‘genotype’: F1,21=5.2, p < 0.04; ‘time’: F6,97= 12.6, p < 0.001; ‘genotype’ x ‘time’ 
interaction: F6,71= 0.7, p > 0.6). 
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Supplementary material Table S2 
Table S1. Cognitive assessment of study participants. 
 
G/A genotype G/G genotype ‘genotype’ ‘gender’ ‘genotype*gender’ 
Attention 
d2 Task:   F1, 216 (p) F1, 216 (p) F1, 216 (p) 
Number of processed items 503.2 ± 12.4 533.7 ± 5.3 4.6 (0.03) 1.0 (0.31) 0.3 (0.60) 
Sum of omission and commission errors 21.4 ± 3.3 24.0 ± 1.4 0.6 (0.45) 0.7 (0.40) 2.0 (0.16) 
Total number of items processed minus errors 481.8 ± 12.5 509.6 ± 5.5 3.6 (0.06) 1.4 (0.23) 0.0 (0.87) 
Fluctuation rate 11.4 ± 0.7 11.5 ± 0.3 0.0 (0.93) 0.1 (0.78) 0.2 (0.66) 
Learning efficiency and memory decline 
Rey Auditory Verbal Learning Test (RAVLT)   F1, 216 (p) F1, 216 (p) F1, 216 (p) 
Total number of total words recalled across five trials 56.7 ± 1.5 55.5 ± 0.6 0.6 (0.45) 3.6 (0.06) 0.0 (0.93) 
Immediate recall 12.6 ± 0.3 12.5 ± 0.1 0.1 (0.78) 6.8 (0.01) 0.2 (0.68) 
Delayed recall 12.7 ± 0.4 12.3 ± 0.2 1.1 (0.29) 12.3 (0.001) 0.9 (0.34) 
Rey Visual Design Learning Test (RVDLT)      
Total number of total figures recalled across five trials 55.7 ± 2.0 55.5 ± 0.6 0.2 (0.64) 1.6 (0.20) 1.2 (0.27) 
Immediate recall 13.1 ± 0.5 13.1 ± 0.2 0.0 (0.86) 1.9 (0.17) 1.5 (0.22) 
Delayed recall 13.1 ± 0.5 13.2 ± 0.2 0.0 (0.93) 1.7 (0.19) 1.3 (0.26) 
Working memory 
Digit span test   F1, 215 (p) F1, 215 (p) F1, 215 (p) 
Number of digits recalled during forward run 6.6 ± 0.2 6.8 ± 0.1 0.8 (0.37) 0.7 (0.40) 0.2 (0.70) 
Number of digits recalled during backward run 5.6 ± 0.3 5.6 ± 0.1 0.0 (0.91) 1.4 (0.24) 7.6 (0.01) 
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Supplementary material Table S2 
Table S1. Cognitive assessment of study participants (continued). 
 
G/A genotype G/G genotype ‘genotype’ ‘gender’ ‘genotype*gender’ 
Executive functioning 
Stroop color-word test   
 
F1, 216 (p) F1, 216 (p) F1, 216 (p) 
 Interference score in milliseconds (s) 6.4 ± 0.6 7.0 ± 0.3 0.5 (0.49) 1.6 (0.21) 0.1 (0.76) 
Random Number Generation Test 
  
F1, 216 (p) F1, 216 (p) F1, 216 (p) 
Redundancy 0.9 ± 0.1 0.8 ± 0.0 0.5 (0.50) 0.4 (0.54) 0.1 (0.74) 
Adjacency 35.0 ± 1.2 38.1 ± 0.7 3.1 (0.08) 0.0 (0.99) 2.5 (0.11) 
Go/ no-go Task 
  
F1, 209 (p) F1, 209 (p) F1, 209 (p) 
Reaction time in milliseconds (ms) 429.0 ± 6.2 418.2 ± 3.3 1.5 (0.23) 0.6 (0.45) 1.7 (0.19) 
Nonverbal fluency test (5 point test)   F1, 216 (p) F1, 216 (p) F1, 216 (p) 
Sum of admissible figures designed during 3 minutes 44.7 ± 1.9 45.2 ± 0.7 0.1 (0.83) 0.1 (0.72) 0.1 (0.70) 
Verbal fluency test (s word test)   F1, 216 (p) F1, 216 (p) F1, 216 (p) 
Sum of admissible words produced during 3 minutes 34.0 ± 1.7 35.6 ± 0.7 0.7 (0.42) 6.5 (0.01) 3.6 (0.06) 
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Supplementary material Table S1 
Table S2. Demographic characteristics of participants in sleep study. 
 
22G>A genotype p-value 
 
G/A G/G 
 
Sex ratio (females / males) 5/6 5/6 n/a 
Age (years) 24.3 ± 1.2 24.5 ± 1.0 0.7 
Years of education 12.1 ± 0.5 12.7 ± 0.5 0.4 
Alcohol consumption (drinks/week) 4.0 ± 0.9 2.6 ± 0.6 0.2 
Caffeine consumption (mg/day) 149.6 ± 33.6 181.4 ± 38.4 0.6 
Body mass index (kg/m2) 21.8 ± 0.6 21.9 ± 0.4 0.9 
Trait Anxiety 33.0 ± 1.9 35.5 ± 2.4 0.5 
Chronotype 2.6 ± 0.2 3.0 ± 0.2 0.1 
Daytime sleepiness 6.5 ± 1.0 5.0 ± 0.8 0.3 
Values represent means ± SEM (n = 11 per group). 
Values of caffeine consumption were based on the following average caffeine content per serving: 
Coffee: 100 mg; Ceylon or green tea: 30 mg; Cola drink: 40 mg (2 dl); Energy drink: 80 mg (2 dl); 
Chocolate: 50 mg (100 g). Trait anxiety, diurnal preference (“chronotype”) and daytime sleepiness 
were assessed with the Trait-State Anxiety Inventory (Spielberger et al. 1970), the Horne-Östberg 
Morningness-Eveningness Questionnaire (Horne and Östberg 1976) and the Epworth Sleepiness 
Scale (Johns 1991). The chronotypes were classified based upon the absolute Horne-Östberg score (in 
parentheses): 1 = definite evening type (16-30), 2 = moderate evening type (31-41), 3 = neutral type 
(42-58), 4 = moderate morning type (59-69), 5 = definite morning type (70-86). 
P-values refer to paired, 2-tailed t-tests. 
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Table S3. The 22G>A polymorphism of ADA does not affect habitual sleep duration. 
Sleep duration G/A genotype G/G genotype 
 
MCTQ Actigraphy MCTQ Actigraphy 
Work days 7.2 ± 0.4 7.3 ± 0.2 7.3 ± 0.3 7.5 ± 0.2 
Leisure days 8.6 ± 0.4 8.2 ± 0.3 8.2 ± 0.3 8.2 ± 0.4 
Average over work and leisure days 7.6 ± 0.3 7.6 ± 0.2 7.6 ± 0.3 7.7 ± 0.2 
Mean values ± SEM (hours) in 11 G/A and 11 G/G allele carriers. 
Average values over work and leisure days were calculated by weighing 5 work and 2 leisure days. 
MCTQ: Munich ChronoType Questionnaire (Roenneberg et al. 2003). To objectively estimate 
habitual sleep duration, volunteers continuously wore a rest-activity monitor (actigraphy) and kept a 
sleep-wake diary during 4 weeks at home. The monitor data were missing in 2 G/G genotype subjects. 
Sleep duration refers to the difference between start and end times of the estimated nocturnal rest 
episode. In both genotypes, MCTQ and actigraphy revealed longer sleep on leisure days than on work 
days (pall < 0.006, paired 2-tailed t-tests). 
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Table S4. Visually scored sleep variables in baseline and recovery nights. 
Variable G/A genotype G/G genotype ‘genotype’ ‘condition’ ‘genotype’ x ‘condition’ 
 
Baseline Recovery Baseline Recovery F1,30 (p <) F1,30 (p <) F1,30 (p <) 
Sleep episode 466.1 ± 4.4 476.2 ± 0.8 463.0 ± 4.3 476.9 ± 0.5 0.2 (0.70) 14.7 (0.001) 0.4 (0.55) 
Total sleep time 453.6 ± 5.7 466.7 ± 1.3 447.7 ± 4.4 465.9 ± 1.2 0.8 (0.37) 18.8 (0.001) 0.5 (0.49) 
Sleep efficiency 94.6 ± 1.2 97.2 ± 0.3 93.4 ± 0.9 97.1 ± 0.2 0.9 (0.36) 18.0 (0.001) 0.5 (0.48) 
Sleep latency 13.3 ± 4.4 3.8 ± 0.8 16.5 ± 4.3 3.2 ± 0.5 0.2 (0.69) 13.6 (0.001) 0.4 (0.55) 
REM latency 76.1 ± 8.9 91.2 ± 13.1 73.9 ± 7.3 73.2 ± 8.8 1.1 (0.31) 0.5 (0.47) 0.7 (0.43) 
WASO 3.9 ± 1.6 0.5 ± 0.2 4.2 ± 0.6 1.0 ± 0.3 0.1 (0.72) 8.6 (0.01) 0.01 (0.94) 
Stage 1 32.2 ± 3.9 20.1 ± 5.3 31.7 ± 3.9 16.2 ± 3.2 0.4 (0.52) 17.6 (0.001) 0.3 (0.61) 
Stage 2 196.6 ± 7.9 162.7 ± 4.5** 212.1 ± 4.8 207.1 ± 6.2 26.7 (0.001) 11.3 (0.003) 6.2 (0.02) 
Slow wave sleep 123.9 ± 7.2** 191.2 ± 8.2** 100.3 ± 6.1 153.0 ± 4.2 51.6 (0.001) 194.7 (0.001) 2.9 (0.11) 
REM sleep 100.9 ± 5.4 92.8 ± 3.8 103.6 ± 4.2 89.7 ± 7.0 0 (0.98) 4.5 (0.05) 0.3 (0.59) 
Movement time 8.7 ± 0.8 9.0 ± 0.9 11.1 ± 1.7 9.9 ± 1.1 3.0 (0.10) 0.2 (0.68) 0.7 (0.43) 
Mean values ± SEM in 11 G/A and 11 G/G allele carriers in minutes (except sleep efficiency [%]) for the first 480 minutes from lights-off. Baseline: baseline 
night. Recovery: recovery night after 40 hours prolonged wakefulness. Sleep episode: time after sleep onset until final awakening. Sleep efficiency: total sleep 
time per 480 min. Sleep latency: time from lights-off to first occurrence of stage 2 sleep. REM latency: time from sleep onset to first occurrence of REM 
sleep. WASO: waking after sleep onset. Slow wave sleep: combined stages 3 & 4. 
F- and p-values: 2-way mixed-model ANOVA with within-subjects factors ‘genotype’ (G/A, G/G) and ‘condition’ (baseline, recovery).  
** p < 0.001 (G/A vs. G/G genotype; paired, 2-tailed t-test) 
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